Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
BEELINE HOLDINGS INC (BLNE)
NASDAQFinancialsFinancial - MortgagesSnapshot 2026-11-04
$0.61-12.30%
Close 2026-11-05 · 1-day change
NASDAQFinancialsFinancial - MortgagesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.47 → 0.47 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BLNE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Simplify capital structure by exchanging Series A preferred stock | A supporting condition in BEELINE HOLDINGS INC's published investment case. The stated target is Exchange completed or progressing. | Intact | Exchange fails or reverses in next 4 quarters | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making growth story, not an established compounder. The long-term thesis is on watch: management has made progress on stated growth priorities, but recent financial performance is weak and the signal has turned cautious.
The valuation evidence is mixed: BLNE is described as cheap versus peers, while another measure shows a 31% premium to peers. The expectations gap is negative, which points to expectations that remain demanding despite the weak results; the evidence does not show that expectations are already low.
Near term, results may remain uneven: the company missed earnings in August, performance is well below its industry cohort, and the estimated chance of a next-quarter miss is elevated. Over the multi-year view, revenue has edged up from $2.3 million in 2025-Q3 to $2.6 million in 2026-Q2, and management says it is progressing toward its end-2027 revenue run-rate goal; AI integration is also progressing, while the equity platform’s progress is mixed.
The thesis needs revenue growth and platform development to translate into stronger financial performance, while management delivers on its stated goals. A guidance cut would be a meaningful negative, while continued earnings strength and higher guidance from sector peers could support sector momentum; the effect of rate cuts is also a stated risk.
For the next 1 to 3 years, BLNE remains an execution-dependent, high-risk growth story with some signs of progress but weak recent results and elevated near-term earnings risk. The thesis hinges on sustained delivery, not just stated ambitions. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in BEELINE HOLDINGS INC's published investment case. The stated target is Partnership established and advancing. |
| Improving |
| Partnership fails or stalls in next 4 quarters |
Qualitative: LOI signed 2026-07-28, advancing BLNE entered a non-binding LOI with TYTL Holdings for an all-stock business combination on July 28, 2026. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches at least $100 million in 2026 | A primary condition in BEELINE HOLDINGS INC's published investment case. The stated target is >= $100 million. | Intact | Revenue falls below $100 million in FY26 | Revenue: $2.625M FY2026-Q2; GAAP. Published target: >= $100 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 20262,625,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to at least $100 million in 2027 | A primary condition in BEELINE HOLDINGS INC's published investment case. The stated target is >= $100 million. | Intact | Revenue falls below $100 million in FY27 | Revenue: $2.625M FY2026-Q2; GAAP. Published target: >= $100 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 20262,625,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.47 → $0.47 · observed estimates
$0.06B → $0.06B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-07-25 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-07-26 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-07-27 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-07-28 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-07-29 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-07-30 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-07-31 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-01 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-02 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-03 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-04 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-05 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-06 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-07 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-08 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-09 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-10 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-11 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-12 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-13 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-14 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-15 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-16 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-17 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-18 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-19 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-20 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-21 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-22 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-23 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-24 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-25 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-26 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-27 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-28 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-29 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-30 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-08-31 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-01 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-02 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-03 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-04 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-05 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-06 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-07 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-08 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-09 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-10 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-11 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-12 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-13 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-14 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-15 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-16 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-17 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-18 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-19 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-20 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-21 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-22 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-23 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-24 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-25 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-26 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-27 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-28 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-29 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-09-30 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-01 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-02 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-03 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-04 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-05 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-06 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-07 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-08 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-09 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-10 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-11 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-12 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-13 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-14 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-15 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-16 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-17 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-18 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-19 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-20 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-21 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-22 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-23 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-24 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-25 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-26 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-27 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-28 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-29 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-30 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-10-31 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-11-01 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-11-02 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-11-03 | $0.47 | $63,351,000 | 1 / 1 |
| 2026-11-04 | $0.47 | $63,351,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.